http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007086932-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4ec94161c47493d9fe658cb58634e36
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7f00aa3ac46492a044a5a1506632bb
publicationDate 2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007086932-A3
titleOfInvention Prostate stem cell antigen vaccines and uses thereof
abstract This invention relates to the identification of prostate stem cell antigen (PSCA) as a target of clinically relevant antitumor immune responses. The invention provides vaccines comprising PSCA, or fragments thereof, which are useful in inducing antitumor immune responses, including PSCA specific CD8+ T cell responses. Methods of using the compositions to treat cancer are also provided. The invention further provides methods of identifying compounds useful in antitumor vaccines and methods of assessing the responses of patients to cancer immunotherapy.
priorityDate 2006-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0140309-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0105427-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005014780-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005221400-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0032752-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9840403-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006076678-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004006837-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129001639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128076992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128874790

Total number of triples: 37.